Trials in progress: TAM kinase inhibitor PF-07265807 and sasanlimab plus axitinib in patients with advanced or metastatic renal cell carcinoma-A phase 1, open-label, pharmacokinetic, safety and tolerability study.
Axitinib;PF-07265807;Sasanlimab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Trials in progress: TAM kinase inhibitor PF-07265807 and sasanlimab plus axitinib in patients with advanced or metastatic renal cell carcinoma-A phase 1, open-label, pharmacokinetic, safety and tolerability study. ### Output: Axitinib;PF-07265807;Sasanlimab